Provided by Tiger Trade Technology Pte. Ltd.

AstraZeneca PLC

156.90
-0.8000-0.51%
Post-market: 156.900.00000.00%16:15 EDT
Volume:2.64M
Turnover:414.75M
Market Cap:243.35B
PE:23.49
High:158.80
Open:158.46
Low:156.41
Close:157.70
52wk High:212.71
52wk Low:153.41
Shares:1.55B
Float Shares:1.50B
Volume Ratio:1.03
T/O Rate:0.18%
Dividend:3.16
Dividend Rate:2.02%
EPS(TTM):6.68
EPS(LYR):6.54
ROE:21.96%
ROA:8.02%
PB:4.84
PE(LYR):23.99

Loading ...

Dow Jones Top Company Headlines at 11 am ET: GE Aerospace to Buy Consolidated Precision Products | GameStop ...

Dow Jones
·
Sep 08

Amgen Says Phase 3 Study Meets Primary Endpoint in Small Cell Lung Cancer

MT Newswires Live
·
Sep 08

AstraZeneca Says Lung-Disease Drug Shows Benefits Across Patient Groups

Dow Jones
·
Sep 08

AstraZeneca Says Tozorakimab Cuts COPD Exacerbations in Phase 3 Trials

MT Newswires Live
·
Sep 08

Guardant Health's Breast Cancer Diagnostic Approved by US FDA

MT Newswires Live
·
Sep 08

AstraZeneca PLC Stock Rises Monday, Outperforms Market

Dow Jones
·
Sep 08

AstraZeneca's Etcamah Opens New Breast-Cancer Treatment Paradigm

Dow Jones
·
Sep 07

J.P. Morgan Sticks to Its Buy Rating for AstraZeneca (AZN)

TIPRANKS
·
Sep 07

Jefferies Sticks to Its Buy Rating for AstraZeneca (AZN)

TIPRANKS
·
Sep 07

AstraZeneca Scores Minor Positive with U.S. Approval for Breast-Cancer Drug

Dow Jones
·
Sep 07

Citi Keeps Their Buy Rating on AstraZeneca (AZN)

TIPRANKS
·
Sep 07

AstraZeneca Gets FDA Approval for Breast Cancer Treatment

Dow Jones
·
Sep 05

AstraZeneca PLC Stock Falls Friday, Underperforms Market

Dow Jones
·
Sep 05

Alnylam's Zilebesiran Sees Commercial Opportunity From Baxfendy Launch, Oppenheimer Says

MT Newswires Live
·
Sep 04

AstraZeneca's New Lung Treatment Could Become Market Leader

Dow Jones
·
Sep 03

Berenberg Bank Reaffirms Their Buy Rating on AstraZeneca (AZN)

TIPRANKS
·
Sep 03

AstraZeneca PLC Stock Rises Wednesday, Outperforms Market

Dow Jones
·
Sep 03

Deutsche Bank Sticks to Its Sell Rating for AstraZeneca (AZN)

TIPRANKS
·
Sep 02

Global Pharma Companies That Have Publicly Announced Trump Drug Pricing Agreements

Reuters
·
Sep 01

AstraZeneca completes global license agreement for Zegfrovy in lung cancer

TIPRANKS
·
Sep 01